Device Device

Organ Care System

Payments companies reported to CMS as associated with Organ Care System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.6Massociated payments (2023-2025)
420clinicians with associated payments
1company reporting

By year

2023 $1.1M
2024 $851K
2025 $629K

Payments reported as associated with Organ Care System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $656K
Surgery $508K
Advanced Heart Failure and Transplant Cardiology $444K
Transplant Surgery $409K
Pulmonary Disease $381K
Cardiovascular Disease $54K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Organ Care System

These are the largest totals companies reported as associated with Organ Care System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Marshall Hertz Minneapolis, MN Pulmonary Disease $177,090.21
Carmelo Milano Lumberton, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $145,898.13
Maryjane Farr Dallas, TX Advanced Heart Failure and Transplant Cardiology $143,215.08
Josef Stehlik Salt Lake City, UT Advanced Heart Failure and Transplant Cardiology $143,202.31
Sean Pinney New York, NY Advanced Heart Failure and Transplant Cardiology $141,658.26
Gabriel Loor Houston, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $100,439.00
Rafik Ghobrial Houston, TX Transplant Surgery $67,845.22
Marie Budev Cleveland, OH Pulmonary Disease $54,392.13
Kenneth Mccurry Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $53,956.73
Puneet Garcha Silver Spring, MD Pulmonary Disease $53,059.94

Prescribed Organ Care System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.